Feb 27, 2012 0
By: Dr. Evian Gordon
(Editor’s Note: this is Part 3 of the new 3-part series written by Dr. Evian Gordon drawing from his participation at the Personalized Medicine World Congress on January, 23, 2012 at Stanford University.)
Working with Health Care Industry Stakeholders: Clinicians, Pharma/Biotech, Payers, PBMs, Lawyers, Medicare, FDA
Clinicians seek clear validated “rules of thumb” that can be easily implemented and fit into their workflow and reimbursement regime. Many are exploring “Clinical Decision Support (CDS)” tools on the web and solutions linked to “Electronic Health Records” (EHR’s). CDC and EHR’s are seeding the ground for clinicians to adopt robust Biomarkers that are shown to be unambiguously clinically relevant.